It is while putting away her medicines that a patient would have put a sleeping pill in a packet of Furosemide. Teva does not wish to take legal action.
The case of the badly conditioned box of Furosemide is finally clarified! According to Liberation, it is the first patient at the origin of the alert who made a mistake by putting away her tablets.
Asked Tuesday evening on Europe 1, the head of laboratories Teva France confirmed the information: “The report concludes that the only hypothesis is that the patient herself has positioned a tablet of Zopiclone in the packaging of the diuretic”, a- he explained. “This patient is used to opening her medicine boxes in advance to put them in her pill organizer. When she opens too many, she reposition them in their box conscientiously, closing the aluminum lid tightly. The Saint-Malo pharmacist’s assistant was therefore unable to realize that the packaging had already been opened, ”he added.
However, despite the accusations that have been brought against the laboratory for a time, Teva will not take legal action in this case. Erik Roche comments on this choice, explaining that “ dn this affair, everyone is in good faith, there is no malice, no will to harm, just the awkwardness of an elderly lady ”, he explains.
As a reminder, following the alert from a pharmacist in Saint-Malo who claimed to have found a tablet of zopiclone Teva in a blister pack of Furosemide, two batches of the diuretic identified as problematic were first recalled, before the entire lots is withdrawn from the market. A systematic check under the supervision of a bailiff of the boxes of Furosemide recovered in the context of the recall had then taken place. In the end, 12,000 boxes were opened, 24,000 blisters, or 360,000 tablets. Among them, no non-compliant tablet was detected. And next, the Teva packaging site in Sens (Yonne), where Furosemide Teva and Zopiclone Teva were packaged, had been searched. This search had also given nothing.
Finally, concerning the judicial aspect of the case, the prosecution of the Tribunal de Grande Instance (TGI) of Paris announced at the end of June the dismissal for lack of infringement of the preliminary investigation opened earlier in the month for implementation. danger to the life of others, aggravated deception, administration of harmful substances, homicides and unintentional injuries.
.
